Ibits the development of advanced-stage triple-negative breast cancer xenografts. Mol Cancer Ther 2013, 12:131?40. Conley SJ, Gheordunescu E, Kakarala P, Newman B, Korkaya H, Heath AN, Clouthier SG, Wicha MS: Antiangiogenic agents enhance breast cancer stem cells through the generation of tumor hypoxia. Proc Natl Acad Sci U S A 2012, 109:2784?789. Burstein HJ, Elias AD, Rugo HS, Cobleigh MA, Wolff AC, Eisenberg PD, Lehman M, Adams BJ, Bello CL, DePrimo SE, Baum CM, Miller KD: Phase II study of sunitinib malate, an oral multitargeted tyrosine kinase inhibitor, in patients with metastatic breast cancer previously treated with an anthracycline along with a taxane. J Clin Oncol 2008, 26:1810?816. Folkman J: Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007, 6:273?86. Johannsen M, Fl cken A, Bex A, Roigas J, Cosentino M, Ficarra V, Kloeters C, Rief M, Rogalla P, Miller K, Gr wald V: Can tyrosine kinase inhibitors be discontinued in patients with metastatic renal cell carcinoma in addition to a comprehensive response to therapy? A multicentre, retrospective analysis. Eur Urol 2009, 55:1430?438. Bergers G, Hanahan D: Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008, eight:592?03. Lu X, Kang Y: Hypoxia and hypoxia-inducible components: master regulators of metastasis. Clin Cancer Res 2010, 16:5928?935. Soeda A, Park M, Lee D, Mintz A, Androutsellis-Theotokis A, McKay RD, Engh J, Iwama T, Kunisada T, Kassam AB, Pollack IF, Park DM: Hypoxia promotes expansion with the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 2009, 28:3949?959. Seidel S, Garvalov BK, Wirta V, von Stechow L, Sch zer A, Meletis K, Wolter M, Sommerlad D, Henze AT, Nist M, Reifenberger G, Lundeberg J, Fris J, Acker T: A hypoxic niche regulates glioblastoma stem cells by way of hypoxia inducible factor 2 alpha. Brain 2010, 133(Pt four):983?95. Farnie G, Clarke RB: Mammary stem cells and breast cancer-role of Notch signaling. Stem Cell Rev 2007, 3:169?75. Farnie G, Clarke RB, Spence K, Pinnock N, Brennan K, Anderson NG, Bundred NJ: Novel cell culture strategy for main ductal carcinoma in situ: part of Notch and epidermal development element receptor signaling pathways. J Natl Cancer Inst 2007, 99:616?27. Gu JW, Rizzo P, Pannuti A, Golde T, Osborne B, Miele L: Notch signals within the endothelium and cancer “stem-like” cells: possibilities for cancer therapy. Vasc Cell 2012, four:7. Gu JW, Fortepiani L, Reckelhoff JF, Adair TH, Wang J, Hall JE: Enhanced expression of vascular endothelial development issue and capillary density in hearts of spontaneously hypertensive rats. Microcirculation 2004, 11:689?97. Gu JW, Bailey AP, Sartin A, Makey I, Brady AL: Ethanol stimulates tumor progression and expression of vascular endothelial growth element in chick embryos.Formula of 27194-74-7 Cancer 2005, 103:422?31.Ethyl 3-chloro-1H-pyrazole-4-carboxylate web Yun J, Pannuti A, Espinoza I, Zhu H, Hicks C, Zhu X, Rizzo P, D’Souza G, Backus K, Denning MF, Coon J, Sun M, Bresnick EH, Osipo C, Wu J, Strack PR, Tonetti DA, Miele L: Crosstalk in between PKC and Notch-4 in endocrine-resistant breast cancer cells.PMID:33450748 Oncogenesis 2013, 2:e60. Brown LF, Berse B, Jackman RW, Tognazzi K, Guiddi AJ, Dvorak HF, Senger DR, Connolly JL, Schnitt SJ: Expression of vascular permeability issue (vascular endothelial development aspect) and its receptors in breast cancer. Hum Pathol 1995, 26:86?1. Lee TH, Seng S, Sekine M, Hinton C, Fu Y, Avraham HK, Avraham S: Vascular endothelial growth factor mediates intracrine survival in human breastChinchar et al. Vascular.